Claim Missing Document
Check
Articles

Found 5 Documents
Search

PEMANFAATAN EKSTRAK VIRGIN COCONUT OIL UNTUK TUMIT PECAH-PECAH Besti Wika Presilia; Buwono Puruhito; Holy Ametati
Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal) Vol 6, No 3 (2017): JURNAL KEDOKTERAN DIPONEGORO
Publisher : Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.14710/dmj.v6i3.18389

Abstract

Latar belakang: Tumit pecah-pecah merupakan suatu keadaan klinis yang di tandai dengan terdapatnya fisura pada tumit. Fisura yang terjadi pada tumit pecah akibat dari kulit kering. Ekstrak Virgin Coconut Oil dapat dijadikan sebagai bahan dasar pelembab untuk tumit pecah-pecah.Tujuan: Mengetahui manfaat ekstrak Virgin Coconut Oil untuk tumit pecah-pecah.Metode: Penelitian ini merupakan penelitian eksperimental dengan rancangan one-group pre-test post-test design menggunakan 29 responden yang diperoleh dengan cara purposive sampling. Responden mengisi kuesioner. Kemudian dilakukan pemotretan keadaan tumit pecah-pecah sebelum pemakaian Virgin Coconut Oil. Lalu responden diberi produk penelitian yang dioleskan pada tumit pecah-pecah dua kali sehari selama 28 hari. Terakhir, dilakukan pemotretan untuk melihat keadaan tumit pecah-pecah setelah pemakaian Virgin Coconut Oil. Analisis data menggunakan uji Wilcoxon.Hasil: Dari 29 responden yang memakai produk penelitian, 12 responden mengalami penurunan skor XSS dan 17 responden tidak mengalami peningkatan maupun penurunan skor XSS setelah pemberian produk penelitian selama 28 hari. Dari uji normalitas Shapiro-Wilk didapatkan hasil p=0,002 sehingga sesuai dengan uji hipotesis Wilcoxon terdapat perbedaan bermakna sebelum dan sesudah pemakaian VCO.Simpulan: Ekstrak Virgin Coconut Oil efektif untuk mengurangi tingkat keparahan tumit pecah-pecah.
Herpes Zoster Otikus Dengan Paresis Nervus Fasialis (Sindrom Ramsay Hunt) Pada Pasien Imunokompromais Ametati, Holy; Avianggi, Hayra Diah
Medica Hospitalia : Journal of Clinical Medicine Vol. 7 No. 1 (2020): Med Hosp
Publisher : RSUP Dr. Kariadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (377.013 KB) | DOI: 10.36408/mhjcm.v7i1.437

Abstract

Latar belakang: Sindrom Ramsay Hunt (SRH) merupakan komplikasi yang jarang terjadi pada herpes zoster. SRH dapat terjadi tanpa adanya ruam kulit (zoster sine herpete). Karena gejala-gejala ini tidak selalu muncul saat onset, sindrom ini sering salah didiagnosis. Insidensi 5/100.000 kasus pada populasi di Amerika Serikat dan meningkat pada kelompok umur di atas 60 tahun dan kondisi imunokompromais. Laporan Kasus: Laki-laki, 66 tahun, timbul plenting-plenting di daerah telinga kiri menyebar ke dada sebelah kiri sejak 8 hari sebelum dikonsulkan. Terdapat nyeri pada telinga, pendengaran berkurang, pusing berputar, wajah sebelah kiri sulit digerakkan dan sulit berbicara. Permeriksaan fisik ditemukan vesikel berkelompok dengan dasar kulit eritem dan edema, bula, erosi, krusta, konfigurasi herpetiformis, distribusi unilateral, segmental setinggi persarafan servikal 2-4. Temuan tzank test menunjukkan sel datia berinti banyak. Penatalaksanaan dengan sistemik asiklovir dan metilprednison. Pembahasan: SRH merupakan hasil reaktivasi virus varicella zoster laten diganglion genikulatum yang menyebabkan vesikel pada aurikula, otalgia dan paresis/paralisis fasialis. Mekanisme pencetus reaktivasi pada pasien ini diduga berhubungan dengan imunokompromais (keganasan). Pasien imunokompromais memiliki resiko 20-100 kali lebih besar. Pemeriksaan Tzank sesuai dengan gambaran herpes zoster. Terapi SRH yang paling disarankan adalah terapi kombinasi antivirus dan kortikosteroid. Kesimpulan: Telah dilaporkan kasus herpes zoster otikus dengan paresis nervus fasialis (Sindrom Ramsay Hunt) pada pasien imunokompromais. Hasil terapi memuaskan. Prognosis qua ad vitam ad bonam, ad sanam dubia ad malam, ad cosmeticam dubia ad bonam. Kata kunci: Sindrom Ramsay Hunt, Herpes Zoster Otikus, Paresis Nervus Fasialis, Immunokopromais. Background; Ramsay Hunt Syndrome (RHS) is a rare complication in shingles. RHS can occur without the presence of skin rash (zoster sine herpete). Because these symptoms do not always appear at onset, RHS is often misdiagnosed. The incidence of 5/100,000 cases in the US and increase in the age above 60 years and immunocompromised. Case: A 66-years-old male complaint of vesicle on the left ear spreading to left chest, since 8 days prior to the consultation. There was otalgia, dizziness, hearing impairment, difficulty in movement and speaking on the left side. Physical examination found clustered vesicle on an erythematosus and oedematous base, bullaes, erosions, crusts, in a herpetiformis configuration, unilateral distribution, in a level of 2-4 cervical nerve innervation. The Tzank test showed multinucleated giant cells. Management with systemic acyclovir and methylprednisolone. Discussion: RHS is the result of reactivation of latent varicella zoster virus in geniculate ganglion which causes vesicles in the auricle, otalgia and facial paresis / paralysis. The mechanism for triggering reactivation in these patients is immunocompromise (malignancy). Immunocompromised have a 20-100 times greater risk. Tzank results in accordance with diagnostic of herpes zoster. The most recommended therapy is combination of antiviral and corticosteroid. Conclusion: The case of herpes zoster oticus with facial nerve paresis (Ramsay Hunt Syndrome) in immunocompromised has been published. The result of therapy was satisfying. The prognosis qua ad vitam ad bonam, ad sanam dubia ad malam, ad cosmetics dubia ad bonam. Keywords: Ramsay Hunt Syndrome, Herpes Zoster Oticus, Facial Nerve Paresis, Immunokopromised.
Platelet-Rich Plasma (PRP) As A New Approach And Promising Therapy In Patients With Alopecia Areata Ametati, Holy; Kadarhadi, Elva; Gunawan, Imelda; Malik, Diah Adriani; Rahayu, Muji
Medica Hospitalia : Journal of Clinical Medicine Vol. 10 No. 1 (2023): Med Hosp
Publisher : RSUP Dr. Kariadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36408/mhjcm.v10i1.818

Abstract

Background: Alopecia areata (AA) is a non-scarring, autoimmune, inflammatory condition that causes well-defined areas of hair loss on the scalp and/or body. A new biotechnology called platelet-rich plasma (PRP) was developed as a result of increased interest in tissue engineering and cell-based therapies. This therapy is defined as an autologous, non-allergic preparation of platelets in concentrated plasma. Study aimed to evaluate the effect of PRP treatment in alopecia areata. Case: This study included 3 patients complaining of multiple patchy alopecia areata. They were treated with combination of PRP therapy, topical fluocinolone acetonide 0.025% cream, minoxidil 2 and 5%, and ketoconazole 2% scalp solution. One patient was also treated with intralesional triamcinolone acetonide injections. PRP was injected intradermally every 4 weeks and final monitoring was conducted after 4-6 sessions. Evaluation and follow up results were determined using photographic monitoring as well as patient’s satisfaction. Results: Administration of autologous PRP had significance hair regrowth in all three patients in this study. PRP treatment sessions varied from 3 to 6 sessions. However, significance outcomes in these patients were established after 3 sessions of PRP treatment, while the best results were obtained after 4-6 sessions of PRP treatment. No major side effects was reported. Conclusion: PRP is effective in promoting hair growth. PRP treatment for alopecia areata is safe, easy to perform, and can achieve patient’s satisfaction, without any major adverse effects. However, further research on standardized protocol of PRP methods are needed.
Fenomena Lucio pada pasien Morbus Hansen tipe Lepromatosa: Suatu Laporan Kasus Langka Amalia, Irma; Widayati, Agnes Sri; Ametati, Holy; Rahmat Sugianto, Yosep Ferdinand; Windayati, Sri
Medica Hospitalia : Journal of Clinical Medicine Vol. 10 No. 3 (2023): Med Hosp
Publisher : RSUP Dr. Kariadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36408/mhjcm.v10i3.998

Abstract

BACKGROUND: Lucio’s phenomenon is a rare leprosy reaction, characterized by severe necrotic cutaneous lesions that generally occur in patients with untreated or inadequately treated lepromatous leprosy (LL). OBJECTIVE: to describe and comprehend the diagnosis and management of Lucio’s phenomenon in leprosy patients CASE: Male, 34 years old with extensive wounds on both arms and legs. About 3 years earlier, the patient felt burning heat in both hands and feet followed by loss of eyebrows and eyelashes, and a change in the shape of the nose. The patient had not received previous therapy. Physical examination showed that the patient appeared anaemic, leonine facies, megalobuli, madarosis, saddle nose, thickening of the ulnar and posterior tibial nerves, deformities of the fingers and toes, and amputations of several fingers. The dermatological status showed multiple ulcers of irregular shape and varying sizes with pus and necrotic tissue. Reitz serum test revealed a bacterial index of +3 with a morphological index of 90%, and routine blood showed hypochromic microcytic anaemia and leucocytosis. The patient received corticosteroid therapy, anti-leprosy combination therapy, antibiotics, iron tablets and wound care. DISCUSSION: Lucio’s phenomenon consists of skin lesions that range from painful red-black patches to flaky blisters and ulcerations. These lesions usually occur on the lower extremities, and may extend proximally and distally. The lesions improved after administration of corticosteroids and anti-leprosy. Delayed diagnosis leads to significant disability and community transmission of the disease. The later the diagnosis, the more serious the disease becomes and can lead to death due to sepsis. Early diagnosis and appropriate treatment are important. CONCLUSION: Early detection is crucial in order to deliver therapy earlier and prevent disease worsening.
Secretome-Based Therapy Promotes Epidermal Thickness Recovery and Follicular Regrowth in Fluconazole-Induced Alopecia in Rats Ametati, Holy; Prawitasari, Salindri; Habibi
International Journal of Cell and Biomedical Science Vol 4 No 11 (2025)
Publisher : Stem Cell and Cancer Research (SCCR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59278/cbs.v4i11.72

Abstract

Background: Alopecia involves hair loss characterized by decreased follicle density and epidermal thinning, which may be exacerbated by prolonged fluconazole exposure. The secretome derived from human umbilical cord mesenchymal stem cells (hUC-MSCs) possesses anti-inflammatory and regenerative properties that could aid follicular repair. Methods: Twenty-four male Wistar rats were randomly assigned to four groups: control, 5% minoxidil, hUC-MSC secretome, and secretome–minoxidil combination. Alopecia was induced by fluconazole administration for seven days, followed by a seven-day treatment period. Histological evaluation using hematoxylin and eosin staining assessed hair follicle count and epidermal thickness. Results: The hUC-MSC secretome group exhibited a significant increase in follicle count (mean 39.2; p < 0.001) compared with the control and minoxidil groups. However, changes in epidermal thickness were not statistically significant (p = 0.133). Conclusion: hUC-MSC secretome effectively enhances follicular regeneration in fluconazole-induced alopecia and represents a promising biotherapeutic approach for hair restoration.